IP Library Granted Patent US 8,632,583
Granted Patent B2
US 8,632,583 · App. 13/103,576 · Granted Jan 21, 2014

Implantable medical device having enhanced endothelial migration features and methods of making the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,632,583
App. No.
13/103,576
Granted
Jan 21, 2014
Kind
B2
Abstract

An implantable medical device having enhanced endothelial migration features, generally comprises: a structural member including a leading edge and a trailing edge interconnected by a third surface region, the leading edge including a second surface region in a generally curvilinear cross-section, and the trailing edge including a fourth surface region in a generally curvilinear cross-section, whereby blood flow over the second surface region generate shear stress at the second surface region without an eddy region in the second surface region.

Claims (26)

1. An implantable medical device having enhanced endothelial migration features, comprising:

a structural member including a leading edge and a trailing edge interconnected by a third surface region, the leading edge including a generally curvilinear cross-section, and the trailing edge including a generally curvilinear cross-section, wherein the leading edge connects to a first edge and the trailing edge connects to a third edge, and the height of the leading edge is above the height of the connecting points of the leading edge and the first edge and above the height of the connecting points of the trailing edge and the third edge; whereby blood flow over the leading edge generates a continuous and increased shear stress at the leading edge and the third surface region without an eddy region in the leading edge:

wherein the leading edge joins the first edge at an angle As, wherein the angle As is less than 90 degrees.

2. The implantable medical device of claim 1 , wherein the shear stress generated at the leading edge is between about 5 and 25 dynes/cm 2 and the migration rate of cells is increased to a rate of 25 μm/hr across the leading edge.

3. The implantable medical device of claim 1 , wherein the leading edge includes a radius of curvature Rs, wherein Rs is between about 1 nm to about 75 mm.

4. The implantable medical device of claim 3 , wherein the leading edge is concave into the structural member.

5. The implantable medical device of claim 4 , wherein the leading edge joins the third surface region at an angle At, wherein the angle At is greater than 90 degrees.

6. The implantable medical device of claim 5 , wherein the length of the third surface region is less than the length of the leading edge.

7. The implantable medical device of claim 6 , wherein the first edge joins a second edge and the second edge joins the third edge, whereby the third edge joins the trailing edge to form a substantially hexagonal cross-section configuration of the structural member.

8. The implantable medical device of claim 7 , wherein the trailing edge includes a radius of curvature Rr, wherein Rr is between about 1 nm to about 75 mm.

9. The implantable medical device of claim 8 , wherein the trailing edge joins the third edge at an angle Ar, wherein the angle Ar is less than 90 degrees.

10. The implantable medical device of claim 9 , wherein the trailing edge joins the third surface region at an angle Aq, wherein the angle Aq is greater than 90 degrees.

11. The implantable medical device of claim 10 , wherein the length of the third surface region is less than the length of the trailing edge.

12. The implantable medical device of claim 11 , wherein the leading edge and the trailing edge each include a plurality of geometric physiologically functional features including a focal adhesion point for affinity binding of endothelial cells.

13. The implantable medical device of claim 11 , wherein the leading edge and the trailing edge each include a plurality of grooves disposed thereon.

14. A method of forming an implantable medical device having enhanced endothelial migration features, comprising:

forming a structural member including a leading edge and a trailing edge interconnected by a fourth face including a third surface region,

forming the leading edge to include a generally curvilinear cross-section, wherein the leading edge connects to a first edge and the trailing edge connects to a third edge, and the height of the leading edge is above the height of the connecting points of the leading edge and the first edge and above the height of the connecting points of the trailing edge and the third edge;

joining the leading edge to the first edge at an angle As, wherein the angle As is less than 90 degrees;

and forming the trailing edge to include a generally curvilinear cross-section, whereby blood flow over the leading edge generates a continuous and increased shear stress at the leading edge and the third surface region without an eddy region in the leading edge.

15. The method of claim 14 , further comprising forming the leading edge to include a radius of curvature Rs, wherein Rs is between about 1 nm to about 75 mm.

16. The method of claim 15 , further comprising forming the leading edge to be concave into the structural member.

17. The method of claim 16 , further comprising joining the leading edge to the third surface region at an angle At, wherein the angle At is greater than 90 degrees.

18. The method of claim 17 , further comprising joining the first edge to a second edge and joining the second edge to the third edge, whereby the third edge joins the trailing edge to form a substantially hexagonal cross-section configuration of the structural member.

19. The method of claim 18 , wherein the trailing edge includes a radius of curvature Rr, wherein Rr is between about 1 nm to about 75 mm.

20. The method of claim 19 , further comprising joining the trailing edge to the third edge at an angle Ar, wherein the angle Ar is less than 90 degrees.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2018
From: VACTRONIX SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, LLC
Reel/Frame 046196/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: PALMAZ SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, INC.
Reel/Frame 042124/0582 →
SECURITY INTEREST Recorded Feb 17, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: OAK COURT PARTNERS, LTD.
Reel/Frame 037839/0278 →
SECURITY INTEREST Recorded Feb 16, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: OAK COURT PARTNERS, LTD.
Reel/Frame 037836/0646 →
SECURITY INTEREST Recorded Feb 16, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: OAK COURT PARTNERS, LTD.
Reel/Frame 037827/0568 →
SECURITY INTEREST Recorded Feb 15, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: PALMAZ, JULIO
Reel/Frame 037820/0400 →
SECURITY INTEREST Recorded Aug 24, 2015
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: SPI DALLAS INVESTMENTS, LP
Reel/Frame 036434/0813 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036384 FRAME: 0818. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 24, 2015
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: LENNOX CAPITAL PARTNERS, LP
Reel/Frame 036465/0091 →
SECURITY INTEREST Recorded Aug 18, 2015
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: SPI DALLAS INVESTMENTS, LP
Reel/Frame 036384/0818 →